Cancer Treatment News and Research

RSS

Breakthrough nanopipette enables real-time observation of cancer cell reactions to treatment

The high-tech double-barrel nanopipette, developed by University of Leeds scientists, and applied to the global medical challenge of cancer, has - for the first time - enabled researchers to see how individual living cancer cells react to treatment and change over time – providing vital understanding that could help doctors develop more effective cancer medication.

6 Mar 2024

New approach needed to better prepare and support women during menopause transition, experts say

A new approach to menopause that better prepares and supports women during midlife is needed – going beyond medical treatments, to empower women using high-quality information on symptoms and treatments, empathic clinical care and workplace adjustments as required, says a new four paper Series published in The Lancet.

6 Mar 2024

Scientists develop robust iPSC-derived rejuvenated T lymphocytes for cervical cancer treatment

Cervical cancer is among the most common malignancies affecting women worldwide. In 2020 alone, approximately 600,000 women were diagnosed with this disease, and over 314,000 died from it.

5 Mar 2024

Robotic-assisted surgery for gallbladder cancer found to be as effective as traditional methods

Each year, approximately 2,000 people die annually of gallbladder cancer (GBC) in the U.S., with only one in five cases diagnosed at an early stage. With GBC rated as the first biliary tract cancer and the 17th most deadly cancer worldwide, pressing attention for proper management of disease must be addressed.

5 Mar 2024

Breakthrough immunotherapy targets non-cancer cells to prevent breast cancer spread

A new type of immunotherapy that targets non-cancer cells could help prevent the growth and spread of breast cancer tumors, according to new research funded by Breast Cancer Now.

4 Mar 2024

Microbial signatures linked to immunotherapy response across cancers

The microbiome can identify those who benefit from combination immunotherapy across multiple different cancers, including rare gynecological cancers, biliary tract cancers and melanoma.

1 Mar 2024

Innovative robot-assisted gastrectomy utilizing 5G communication technology for gastric cancer patients

Globally, gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer-related death, with China bearing nearly half of these cases.

29 Feb 2024

Study reveals high prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients from the Salento peninsula

A new research paper was published in Oncotarget's Volume 15 on February 22, 2024, entitled, "Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health."

28 Feb 2024

Research reveals increased mortality risk in childhood cancer survivors after cardiovascular events

New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indicates that survivors of childhood cancer are at a significantly higher risk of death following a major cardiovascular event -; including heart failure, heart attack or stroke -; than the general public.

27 Feb 2024

Secondhand smoke exposure reduces chemotherapy effectiveness in head and neck cancer patients

People who are diagnosed with head and neck cancer often receive a standard type of chemotherapy as part of their treatment.

27 Feb 2024

Breakthrough research could transform the landscape of ovarian cancer treatment

In a major scientific breakthrough, newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.

27 Feb 2024

Study finds metabolic checkpoint PHGDH as potential target to modulate tumor-associated macrophages

A study by a scientific team from the University of Vienna and the MedUni Vienna, recently published in the top-class journal Cellular & Molecular Immunology, has a promising result from tumor research: The enzyme phosphoglycerate dehydrogenase (PHDGH) acts as a metabolic checkpoint in the function of tumor-associated macrophages (TAMs) and thus on tumor growth.

27 Feb 2024

UK lags in cancer treatment compared to other countries

People in the UK were treated with chemotherapy and radiotherapy less often than in comparable countries and faced long waits for treatments, according to two new studies published in The Lancet Oncology.

26 Feb 2024

Boston College biologist wins NIH grant to study viral insulins for cancer treatment

Boston College Assistant Professor of Biology Emrah Altindis has been awarded a five-year, $2.5-million grant from the National Institutes of Health to study viral insulins and mechanisms related to IGF-1 receptor protein inhibition and its potential applications in cancer treatment.

26 Feb 2024

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Lung cancer is not the most common form of cancer, but it is by far the deadliest.

23 Feb 2024

Understanding how stress accelerates cancer spread

Stress is inevitable. But too much of it can be terrible for our health. Chronic stress can increase our risk for heart disease and strokes.

22 Feb 2024

Natural killer cells lead the charge in cancer treatment innovation

Review synthesizes research on NK cells' role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing preclinical and clinical trials.

22 Feb 2024

Can dietary patterns impact stomach cancer risk?

Eating patterns and indices related to gastric cancer and explored their association with stomach cancer risk.

22 Feb 2024

Red light exposure mitigates blood glucose spikes after meals

Shining a specific frequency of red light on a person's back for 15 minutes can reduce blood sugar levels, according to a new study from City, University of London and UCL.

22 Feb 2024

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue, PhD, associate professor in the Department of Pathology, Sue Chin Lee, PhD, in the Department of Physiology, and David Schwartz, MD, chair of the Department of Radiation Oncology, are part of a scientific leadership group awarded $20 million from the University of Tennessee-Oak Ridge Innovation Institute in partnership with Oak Ridge National Laboratory and the University of Tennessee, Knoxville, to develop new radiopharmaceutical therapies to treat cancer.

21 Feb 2024

Cancer Treatment News and Research

Breakthrough nanopipette enables real-time observation of cancer cell reactions to treatment

New approach needed to better prepare and support women during menopause transition, experts say

Scientists develop robust iPSC-derived rejuvenated T lymphocytes for cervical cancer treatment

Robotic-assisted surgery for gallbladder cancer found to be as effective as traditional methods

Breakthrough immunotherapy targets non-cancer cells to prevent breast cancer spread

Microbial signatures linked to immunotherapy response across cancers

Innovative robot-assisted gastrectomy utilizing 5G communication technology for gastric cancer patients

Study reveals high prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients from the Salento peninsula

Research reveals increased mortality risk in childhood cancer survivors after cardiovascular events

Secondhand smoke exposure reduces chemotherapy effectiveness in head and neck cancer patients

Breakthrough research could transform the landscape of ovarian cancer treatment

Study finds metabolic checkpoint PHGDH as potential target to modulate tumor-associated macrophages

UK lags in cancer treatment compared to other countries

Boston College biologist wins NIH grant to study viral insulins for cancer treatment

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Understanding how stress accelerates cancer spread

Natural killer cells lead the charge in cancer treatment innovation

Can dietary patterns impact stomach cancer risk?

Red light exposure mitigates blood glucose spikes after meals

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

Cancer Research eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News